Multibic

Sodium hydrogen carbonate, the active ingredient in Multibic, is an electrolyte component presented as an intravenous solution for haemodialysis use. It helps correct acid‑base disturbances and electrolyte imbalances during renal replacement therapy. GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Multibic is used as an intravenous electrolyte solution to manage disturbances that arise during renal replacement therapies. - Acute metabolic acidosis in dialysis patients: restores bicarbonate levels and normalises pH. - Electrolyte imbalance correction during haemodialysis: supplies sodium, potassium, magnesium and calcium to maintain plasma homeostasis. - Prevention of hypokalaemia in renal therapy: provides controlled potassium to avoid low serum potassium during treatment.

Multibic may be associated with a range of infusion‑related reactions.

Common Side Effects: - Hypotension: transient drop in blood pressure during infusion. - Nausea: mild gastrointestinal discomfort. - Mild fever: low‑grade temperature rise. - Local infusion site irritation: redness or pain at the catheter site.

Serious or Rare Side Effects: - Severe hyperkalaemia: dangerously high potassium levels. - Cardiac arrhythmia: irregular heart rhythm linked to electrolyte shifts. - Metabolic alkalosis: excessive bicarbonate leading to high pH. - Anaphylactic reaction: rare severe allergic response requiring immediate medical attention.

When using Multibic, clinicians should observe several safety measures. - Renal function monitoring: check serum electrolytes regularly to avoid overload. - Cardiac status assessment: watch for arrhythmias, especially in patients with existing heart disease. - Fluid balance management: ensure total volume does not exceed patient’s tolerance. - Pregnancy considerations: limited data; use only if the potential benefit outweighs risk. - Store below 25°C: keep in the original pack, protect from moisture.

Multibic can interact with other medications that affect electrolyte balance.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of severe hyperkalaemia. - High‑dose calcium supplements: may cause hypercalcaemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor potassium levels. - Beta‑blockers: observe blood pressure changes. - Concurrent IV electrolyte solutions: avoid duplication of ions.